Andreas Sutter
University of Michigan–Ann Arbor(US)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, Molecular Biology Techniques and Applications, Synthesis and pharmacology of benzodiazepine derivatives, Computational Drug Discovery Methods, Effects and risks of endocrine disrupting chemicals
Most-Cited Works
- → Benchmark Data Set for in Silico Prediction of Ames Mutagenicity(2009)355 cited
- → Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma(2004)171 cited
- → Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics(2005)167 cited
- → Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities(2013)125 cited
- → De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma(2022)117 cited
- → Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells(2006)107 cited
- → Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y2-receptors(2002)96 cited
- → Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor(2005)85 cited
- → Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells(2002)83 cited
- → A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)(2003)82 cited